Published in Breast Cancer Res on February 16, 2010
Radiation-induced reprogramming of breast cancer cells. Stem Cells (2012) 1.83
Breast cancer growth and metastasis: interplay between cancer stem cells, embryonic signaling pathways and epithelial-to-mesenchymal transition. Breast Cancer Res (2011) 1.57
Salinomycin as a drug for targeting human cancer stem cells. J Biomed Biotechnol (2012) 1.50
CD44v6 regulates growth of brain tumor stem cells partially through the AKT-mediated pathway. PLoS One (2011) 1.44
Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med (2010) 1.43
Hsp27 participates in the maintenance of breast cancer stem cells through regulation of epithelial-mesenchymal transition and nuclear factor-κB. Breast Cancer Res (2011) 1.13
Cancer stem cells, cancer cell plasticity and radiation therapy. Semin Cancer Biol (2014) 1.08
Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance. Curr Pharm Des (2015) 1.01
Size Does Matter: Why Polyploid Tumor Cells are Critical Drug Targets in the War on Cancer. Front Oncol (2014) 1.00
Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Res Treat (2014) 0.98
The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells (2014) 0.95
CD44 is a biomarker associated with human prostate cancer radiation sensitivity. Clin Exp Metastasis (2011) 0.95
The phenotypic radiation resistance of CD44+/CD24(-or low) breast cancer cells is mediated through the enhanced activation of ATM signaling. PLoS One (2011) 0.94
The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies. Oncologist (2012) 0.92
Oxygen levels do not determine radiation survival of breast cancer stem cells. PLoS One (2012) 0.92
Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. BMC Cancer (2014) 0.91
Radiation-induced Notch signaling in breast cancer stem cells. Int J Radiat Oncol Biol Phys (2013) 0.91
Wound healing and cancer stem cells: inflammation as a driver of treatment resistance in breast cancer. Cancer Growth Metastasis (2015) 0.90
Lung cancer: a classic example of tumor escape and progression while providing opportunities for immunological intervention. Clin Dev Immunol (2012) 0.89
Expanding the use of monoclonal antibody therapy of cancer by using ionising radiation to upregulate antibody targets. Br J Cancer (2014) 0.89
Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Res Treat (2013) 0.88
Exosomes in development, metastasis and drug resistance of breast cancer. Cancer Sci (2015) 0.87
Elevated intrinsic cancer stem cell population in human papillomavirus-associated head and neck squamous cell carcinoma. Cancer (2013) 0.84
Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells. Cell Death Differ (2014) 0.83
Radiation resistance in breast cancer: are CD44+/CD24-/proteosome low/PKH26+ cells to blame? Breast Cancer Res (2010) 0.83
Tumor Cells Surviving Exposure to Proton or Photon Radiation Share a Common Immunogenic Modulation Signature, Rendering Them More Sensitive to T Cell-Mediated Killing. Int J Radiat Oncol Biol Phys (2016) 0.82
Radioresistance of prostate cancer cells with low proteasome activity. Prostate (2011) 0.81
BlueBerry Isolate, Pterostilbene, Functions as a Potential Anticancer Stem Cell Agent in Suppressing Irradiation-Mediated Enrichment of Hepatoma Stem Cells. Evid Based Complement Alternat Med (2013) 0.80
Tie-2 regulates the stemness and metastatic properties of prostate cancer cells. Oncotarget (2016) 0.80
Tumor cell plasticity: the challenge to catch a moving target. J Gastroenterol (2014) 0.79
Lapatinib inhibits stem/progenitor proliferation in preclinical in vitro models of ductal carcinoma in situ (DCIS). Cell Cycle (2013) 0.78
Tumor senescence and radioresistant tumor-initiating cells (TICs): let sleeping dogs lie! Breast Cancer Res (2010) 0.78
Telomeres and Telomerase in the Radiation Response: Implications for Instability, Reprograming, and Carcinogenesis. Front Oncol (2015) 0.78
Downregulation of 26S proteasome catalytic activity promotes epithelial-mesenchymal transition. Oncotarget (2016) 0.78
Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells. Clin Exp Metastasis (2016) 0.77
Targeting the epigenetics of the DNA damage response in breast cancer. Cell Death Dis (2016) 0.76
Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. Exp Cell Res (2016) 0.75
All-trans retinoic acids induce differentiation and sensitize a radioresistant breast cancer cells to chemotherapy. BMC Complement Altern Med (2016) 0.75
Doxycycline inhibits the cancer stem cell phenotype and epithelial-to-mesenchymal transition in breast cancer. Cell Cycle (2016) 0.75
The Role of HPV in Head and Neck Cancer Stem Cell Formation and Tumorigenesis. Cancers (Basel) (2016) 0.75
Differential cell adhesion of breast cancer stem cells on biomaterial substrate with nanotopographical cues. J Funct Biomater (2015) 0.75
Intraoperative full-dose of partial breast irradiation with electrons delivered by standard linear accelerators for early breast cancer. Int J Breast Cancer (2014) 0.75
Functional genomics screening utilizing mutant mouse embryonic stem cells identifies novel radiation-response genes. PLoS One (2015) 0.75
In vivo monitoring of CD44+ cancer stem-like cells by γ-irradiation in breast cancer. Int J Oncol (2016) 0.75
Imaging Reporters for Proteasome Activity Identify Tumor- and Metastasis-Initiating Cells. Mol Imaging (2015) 0.75
Hsp90α Mediates BMI1 Expression in Breast Cancer Stem/Progenitor Cells through Facilitating Nuclear Translocation of c-Myc and EZH2. Int J Mol Sci (2017) 0.75
Enhancement of mTOR signaling contributes to acquired X-ray and C-ion resistance in mouse squamous carcinoma cell line. Cancer Sci (2017) 0.75
Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A (2003) 59.17
Identification of human brain tumour initiating cells. Nature (2004) 38.87
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature (2006) 27.91
Identification and expansion of human colon-cancer-initiating cells. Nature (2006) 24.44
Identification of a cancer stem cell in human brain tumors. Cancer Res (2003) 24.02
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev (2003) 20.77
Cancerous stem cells can arise from pediatric brain tumors. Proc Natl Acad Sci U S A (2003) 10.56
Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature (2009) 10.31
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst (2006) 10.06
Identification of cells initiating human melanomas. Nature (2008) 8.28
Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ (2007) 8.08
A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res (2005) 7.86
Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res (2008) 7.65
WNT/beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci U S A (2007) 4.97
In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst (2009) 2.39
Molecular and cell biology of replicative senescence. Cold Spring Harb Symp Quant Biol (1994) 1.38
Radiation responses of cancer stem cells. J Cell Biochem (2009) 1.08
Tumor initiating cancer stem cells from human breast cancer cell lines. Int J Oncol (2009) 1.04
Differential staining of DNA and RNA. Curr Protoc Cytom (2004) 0.96
Melatonin inhibition of MCF-7 human breast-cancer cells growth: influence of cell proliferation rate. Cancer Lett (1995) 0.85
Cell kinetics and repopulation mechanisms during multifraction irradiation of spheroids. Radiother Oncol (1998) 0.82
The response of CD24(-/low)/CD44+ breast cancer-initiating cells to radiation. J Natl Cancer Inst (2006) 10.06
Constitutively active androgen receptor splice variants expressed in castration-resistant prostate cancer require full-length androgen receptor. Proc Natl Acad Sci U S A (2010) 5.59
Do erythropoietin receptors on cancer cells explain unexpected clinical findings? J Clin Oncol (2006) 5.56
The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med (2008) 5.01
Actin up: regulation of podocyte structure and function by components of the actin cytoskeleton. Trends Cell Biol (2007) 4.31
Synaptopodin orchestrates actin organization and cell motility via regulation of RhoA signalling. Nat Cell Biol (2006) 3.31
Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab (2013) 3.01
In vivo imaging, tracking, and targeting of cancer stem cells. J Natl Cancer Inst (2009) 2.39
Synaptopodin regulates the actin-bundling activity of alpha-actinin in an isoform-specific manner. J Clin Invest (2005) 2.39
Metabolic state of glioma stem cells and nontumorigenic cells. Proc Natl Acad Sci U S A (2011) 2.13
Synaptopodin protects against proteinuria by disrupting Cdc42:IRSp53:Mena signaling complexes in kidney podocytes. Am J Pathol (2007) 2.13
A sense of danger from radiation. Radiat Res (2004) 2.02
Radiation-induced reprogramming of breast cancer cells. Stem Cells (2012) 1.83
Radiation resistance of cancer stem cells: the 4 R's of radiobiology revisited. Stem Cells (2010) 1.78
Safety and efficacy of hyperbaric oxygen therapy for the treatment of interstitial cystitis: a randomized, sham controlled, double-blind trial. J Urol (2006) 1.47
National Institutes of Health funding in radiation oncology: a snapshot. Int J Radiat Oncol Biol Phys (2013) 1.42
Maspin sensitizes breast carcinoma cells to induced apoptosis. Oncogene (2002) 1.38
Ionizing radiation activates the Nrf2 antioxidant response. Cancer Res (2010) 1.35
Maspin expression inhibits osteolysis, tumor growth, and angiogenesis in a model of prostate cancer bone metastasis. Proc Natl Acad Sci U S A (2003) 1.34
Effects of recombinant erythropoietin on breast cancer-initiating cells. Neoplasia (2007) 1.29
Endogenous inhibition of histone deacetylase 1 by tumor-suppressive maspin. Cancer Res (2006) 1.28
Irradiation of the potential cancer stem cell niches in the adult brain improves progression-free survival of patients with malignant glioma. BMC Cancer (2010) 1.19
Tumor-suppressive maspin regulates cell response to oxidative stress by direct interaction with glutathione S-transferase. J Biol Chem (2005) 1.16
Nuclear relocation of the nephrin and CD2AP-binding protein dendrin promotes apoptosis of podocytes. Proc Natl Acad Sci U S A (2007) 1.16
Tumor suppressive maspin and epithelial homeostasis. J Cell Biochem (2006) 1.15
Radiation responses of cancer stem cells. J Cell Biochem (2009) 1.08
Maspin retards cell detachment via a novel interaction with the urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor system. Cancer Res (2006) 1.08
Anthracyclines, proteasome activity and multi-drug-resistance. BMC Cancer (2005) 1.08
Folate-targeted immunotherapy effectively treats established adjuvant and collagen-induced arthritis. Arthritis Res Ther (2006) 1.05
The role of the ubiquitin/proteasome system in cellular responses to radiation. Oncogene (2003) 1.03
Novel streptavidin-functionalized silicon nanowire arrays for CD4+ T lymphocyte separation. Nano Lett (2010) 1.00
Metabolic differences in breast cancer stem cells and differentiated progeny. Breast Cancer Res Treat (2014) 0.98
Maspin reprograms the gene expression profile of prostate carcinoma cells for differentiation. Genes Cancer (2011) 0.97
The RNA-binding protein Musashi-1 regulates proteasome subunit expression in breast cancer- and glioma-initiating cells. Stem Cells (2014) 0.95
Maspin augments proteasome inhibitor-induced apoptosis in prostate cancer cells. J Cell Physiol (2007) 0.95
TIMAP, a novel CAAX box protein regulated by TGF-beta1 and expressed in endothelial cells. Am J Physiol Cell Physiol (2002) 0.95
Anti-inflammatory function of arctiin by inhibiting COX-2 expression via NF-κB pathways. J Inflamm (Lond) (2011) 0.94
Ex vivo expansion of highly cytotoxic human NK cells by cocultivation with irradiated tumor cells for adoptive immunotherapy. Cancer Res (2013) 0.93
Differential expression of immune-associated cancer regulatory genes in low- versus high-dose-rate irradiated AKR/J mice. Genomics (2011) 0.92
Oxygen levels do not determine radiation survival of breast cancer stem cells. PLoS One (2012) 0.92
Tumor cells with low proteasome subunit expression predict overall survival in head and neck cancer patients. BMC Cancer (2014) 0.91
Neu-induced retroviral rat mammary carcinogenesis: a novel chemoprevention model for both hormonally responsive and nonresponsive mammary carcinomas. Cancer Res (2006) 0.91
Radiation-induced Notch signaling in breast cancer stem cells. Int J Radiat Oncol Biol Phys (2013) 0.91
Immunomagnetic diffractometry for detection of diagnostic serum markers. J Am Chem Soc (2007) 0.90
Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation. Biochem Biophys Res Commun (2010) 0.89
NF-kappa B, cytokines, proteasomes, and low-dose radiation exposure. Mil Med (2002) 0.89
Targeted elimination of breast cancer cells with low proteasome activity is sufficient for tumor regression. Breast Cancer Res Treat (2013) 0.88
Differential Effects of the Proteasome Inhibitor NPI-0052 against Glioma Cells. Transl Oncol (2010) 0.88
Effects of CaCl2 on viscosity of culture broth, and on activities of enzymes around the 2-oxoglutarate branch, in Bacillus subtilis CGMCC 2108 producing poly-(γ-glutamic acid). Bioresour Technol (2010) 0.87
Metabolic and phylogenetic analyses based on nitrogen in a new poly-γ-glutamic acid-producing strain of Bacillus subtilis. Biotechnol Lett (2015) 0.86
Auranofin inhibits overproduction of pro-inflammatory cytokines, cyclooxygenase expression and PGE2 production in macrophages. Arch Pharm Res (2008) 0.86
Identification of an intrinsic determinant critical for maspin subcellular localization and function. PLoS One (2013) 0.86
Folate-linked drugs for the treatment of cancer and inflammatory diseases. Subcell Biochem (2012) 0.85
Augmentation of natural cytotoxicity by chronic low-dose ionizing radiation in murine natural killer cells primed by IL-2. J Radiat Res (2012) 0.83
Radiation Therapy Oncology Group translational research program stem cell symposium: incorporating stem cell hypotheses into clinical trials. Int J Radiat Oncol Biol Phys (2009) 0.83
Hyodeoxycholic acid improves HDL function and inhibits atherosclerotic lesion formation in LDLR-knockout mice. FASEB J (2013) 0.83
Targeted cancer stem cell therapies start with proper identification of the target. Mol Cancer Res (2010) 0.82
Optimization of off-null ellipsometry for air/solid interfaces. Appl Opt (2007) 0.81
Radioresistance of prostate cancer cells with low proteasome activity. Prostate (2011) 0.81
Unidirectional signaling triggered through 2B4 (CD244), not CD48, in murine NK cells. J Leukoc Biol (2010) 0.80
Characterization of the stem cell niche and its importance in radiobiological response. Semin Radiat Oncol (2013) 0.80
Androgen-dependent mammary carcinogenesis in rats transgenic for the Neu proto-oncogene. Cancer Cell (2002) 0.80
Imaging of radiation effects on cellular 26S proteasome function in situ. Int J Radiat Biol (2009) 0.79
Immunologic and tissue biocompatibility of flexible/stretchable electronics and optoelectronics. Adv Healthc Mater (2013) 0.79
Folate receptor-β in activated macrophages: ligand binding and receptor recycling kinetics. Mol Pharm (2014) 0.78
Auranofin, an immunosuppressive drug, inhibits MHC class I and MHC class II pathways of antigen presentation in dendritic cells. Arch Pharm Res (2008) 0.76
NKG2D ligation relieves 2B4-mediated NK-cell self-tolerance in mice. Eur J Immunol (2014) 0.76
Myricetin derived from Hovenia dulcis Thunb. ameliorates vascular endothelial dysfunction and liver injury in high choline-fed mice. Food Funct (2015) 0.76
Catch-22: does breast cancer radiotherapy have negative impacts too? Future Oncol (2012) 0.75
Optimization of Off-null Ellipsometry for Optical Biosensor Applications. Conf Proc IEEE Eng Med Biol Soc (2005) 0.75
Mass spectral measurements of the apoHDL in horse (Equus caballus) cerebrospinal fluid. Comp Biochem Physiol Part D Genomics Proteomics (2012) 0.75
Enzyme precipitate coatings of lipase on polymer nanofibers. Bioprocess Biosyst Eng (2011) 0.75
Effects of mizoribine on MHC-restricted exogenous antigen presentation in dendritic cells. Arch Pharm Res (2006) 0.75